Skip to main content

Bayesian Network Meta-Analysis of Postoperative Analgesic Techniques in Thoracoscopic Lung Resection Patients.

Pain and therapy2025-02-23PubMed
Total: 75.5Innovation: 7Impact: 8Rigor: 8Citation: 7

Summary

Across randomized trials, paravertebral block (PVB) ranked best for 24-hour resting and coughing pain, while erector spinae plane block (ESPB) offered favorable safety; thoracic epidural anesthesia (TEA) showed strong early analgesia but was less suitable overall due to side effects. Consistency checks were acceptable, and rankings were robust to meta-regression and sensitivity analyses.

Key Findings

  • SUCRA rankings: at 24 h, PVB > TEA > ESPB > INB > control > SAPB for resting/coughing VAS; at 12 h, TEA led early for resting and coughing pain.
  • PVB consistently ranked highest for 24-hour resting and coughing VAS scores.
  • ESPB identified as suitable with fewer side effects; TEA less suitable overall due to excessive side effects.
  • Network consistency was acceptable with minimal publication bias; meta-regression showed study quality and incision infiltration did not significantly affect outcomes.

Clinical Implications

Prefer PVB for superior 24-hour analgesia after VATS lung resection; consider ESPB when safety and fewer side effects are priorities; limit routine TEA use due to adverse effects while individualizing based on patient risk.

Why It Matters

Provides comparative effectiveness rankings across widely used regional techniques for thoracic surgery, guiding practice toward PVB/ESPB and away from routine TEA where side effects are a concern.

Limitations

  • Heterogeneity in block techniques, dosing, and perioperative protocols across trials
  • Adverse event profiles and long-term functional outcomes were not fully delineated

Future Directions

Head-to-head pragmatic RCTs comparing PVB vs ESPB with standardized outcomes, safety endpoints, and resource use; integration into ERAS pathways for thoracic surgery.

Study Information

Study Type
Meta-analysis
Research Domain
Treatment
Evidence Level
I - Systematic review and network meta-analysis of randomized clinical trials
Study Design
OTHER